Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’

Three investors who previously worked at Lux Capital and Obvious Ventures have teamed up to launch a new venture firm that will start and back young biotechnology companies. Called Dimension, the New York- and San Francisco-based firm has raised $350 million and is focused on companies at the “interface of technology and the life sciences,” according to a Wednesday blog post from the co-founding managing partners.